Persistent distension and enhanced diffusive extravasation of tumor vessels improved uniform tumor targeting of radioimmunoconjugate in mice administered with angiotensin II and kininase inhibitor

Oncology Research

Volumn 10, Issue 11-12, 1998, Pages 551-559

  Kinuya, Seigo ^a,b   Yokoyama, Kunihiko ^a   Yamamoto, Wakako ^a   Kawashima, Atsuhiro ^a,b   Konishi, Shota ^a,b   Hiramatsu, Takashi ^b   Tega, Harunobu ^b   Shuke, Noriyuki ^c   Aburano, Tamio ^d   Watanabe, Naoto ^e  

^a Department of Nuclear Medicine ^*  (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e KANAZAWA UNIVERSITY   (Japan)

Author keywords

Induced hypertension; Kininase inhibitor; Monoclonal antibody; Tumor perfusion; Vascular permeability

Indexed keywords

ANGIOTENSIN II; ANTINEOPLASTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; MONOCLONAL ANTIBODY; SERUM ALBUMIN; THALLIUM;

ANIMAL; ARTICLE; AUTORADIOGRAPHY; BAGG ALBINO MOUSE; COLON TUMOR; CONTRAST MEDIUM EXTRAVASATION; FEMALE; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; RADIOIMMUNOTHERAPY; TISSUE DISTRIBUTION; VASCULARIZATION; XENOGRAFT;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTORADIOGRAPHY; COLONIC NEOPLASMS; ENALAPRIL; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; MICE; MICE, INBRED BALB C; MICE, NUDE; RADIOIMMUNOTHERAPY; SERUM ALBUMIN; THALLIUM RADIOISOTOPES; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032234550     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 131l]anti-B1 (anti-CD20) antibody. N. Engl. J. Med. 329:459-465; 1993.
2. Press, O. W.; Eary, J. F.; Appelbaum, F. R.; Martin, P. J.; Badger, C. C.; Nelp, W. B.; Glenn, S.; Butchko, G.; Fisher, D.; Porter, B.; Matthews, D. C.; Fisher, L. D.; Bernstein, I. D. Radiolabeled antibody therapy of B-cell lymphoma with autologous bone marrow support. N. Engl. J. Med. 329:1219-1224; 1993.
3. Behr, T. M.; Sharkey, R. M.; Juweid, M. E.; Dunn, R. M.; Vagg, R. C.; Ying, Z.; Zhang, C.-H.; Swayne, L. C.; Vardi, Y.; Siegel J. A.; Goldenberg, D. M. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. J. Nucl. Med. 38:858-870; 1997.
4. Breitz, H. B.; Weiden, P. L.; Vanderheyden, J.-L.; Appelbaum, J. W.; Bjorn, M. J.; Fer, M. F.; Wolf, S. B.; Ratliff, B. A.; Seiler, C. A.; Foisie, D. C.; Fisher, D. R.; Schroff, R. W.; Fritzberg, A. R.; Abrams, P. G. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: Results of phase I trials. J. Nucl. Med. 33:1099-1112; 1992.
5. Dyke, P. W.; Bradwell, A. R.; Chapman, C. E.; Vaughan, A. T. M. Radioimmunotherapy of cancer: Clinical studies and limiting factors. Cancer Treat. Rev. 14:87-106; 1987.
6. Ong, G. L.; Mattes, M. J. Penetration and binding of antibodies in experimental human solid tumors grown in mice. Cancer Res. 49:4264-4273; 1989.
7. Sands, H.; Jones, P. L.; Shah, S. A.; Palme, D.; Vessella, R. L.; Gallagher, B. M. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human renal cell xenografts. Cancer Res. 48:188-193; 1988.
8. Li, J.; Merton, D. A.; Thakur, M. L.; Barr, J.; Wilder, S.; O'Hara, M. D.; Gibbons, G.; Goldberg, B. Influence of biological response modifiers: Measurement of tumor blood flow and temperature. J. Immunother. 16:175-180; 1994.
9. 99mTc-labelled monoclonal antibodies. Nucl. Med. Commun. 17:346-352; 1996.
10. Li, J.; Merton, D. A.; Duggaraju, R.; Thakur, M. L. Augmenting of tumor uptake of anti-melanoma antibody MEM 136: Influence of Interferon. Nucl. Med. Biol. 23:873-879; 1996.
11. Shulz, K. R.; Badger, C. C.; Dombi, G. W.; Greenberg, P. D.; Bernstein, I. D. Effect of interleukin-2 on biodistribution of monoclonal antibody in tumor and normal tissues in mice bearing SL-2 thymoma. J. Natl. Cancer Inst. 84:109-113; 1992.
12. LeBerthon, B.; Khawli, L. A.; Alauddin, M.; Miller, G. K.; Charak, B. S.; Mazumdar, A.; Epstein, A. L. Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate. Cancer Res. 51:2694-2698; 1991.
13. Khawli, L. A.; Miller, G. K.; Epstein, A. L. Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors. Cancer Suppl. 73:824-831; 1994.
14. Noguchi, A.; Takahashi, T.; Yamaguchi, T.; Kitamura, K.; Noguchi, A.; Tsurami, H.; Takashima, K.; Maeda, H. Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II. Jpn. J. Cancer Res. 83:240-243; 1992.
15. 111In-labeled monoclonal antibody. Nucl. Med. Biol. 23:137-140; 1996.
16. Kinuya, S.; Yokoyama, K.; Yamamoto, W.; Konishi, S.; Shuke, N.; Aburano, T.; Watanabe, N.; Takayama, T.; Michigishi, T.; Tonami, N. Shoit-period-induced hypertension could improve tumor-to-nontumor ratios of radiolabeled monoclonal antibody. Nucl. Med. Biol. 24:547-551; 1997.
17. Abe, I.; Hori, K.; Saito, S.; Tanda, S.; Li, Y.; Suzuki, M. Increased intratumor concentration of fluorescein-isothiocyanato-labeled neocarzinostatin in rats under angiotensin-induced hypertension. Jpn. J. Cancer Res. 79:874-879; 1988.
18. Suzuki, M.; Hori, K.; Abe, I.; Saito, S.; Sato, H. A new approach of cancer chemotherapy: Selective enhancement of tumor blood flow with angiotensin II. J. Natl. Cancer Inst. 67:663-669; 1981.
19. Matsumura, Y.; Kimura, M.; Yamamoto, T.; Maeda, H. Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn. J. Cancer Res. 79:1327-1334; 1988.
20. Boucher, Y.; Jain, R. K. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: Implications for vascular collapse. Cancer Res. 52:5110-5114; 1992.
21. Zlotecki, R. A.; Boucher, Y.; Lee, I.; Baxter, L. T.; Jain, R. K. Effect of angiotensin II induced hypertension on tumor blood flow and intestitial pressure. Cancer Res. 53:2466-2468; 1993.
22. Netti, P. A.; Baxter, L. T.; Boucher, Y.; Skalak, R.; Jain, R. K. Time-dependent behavior of interstitail fluid pressure in solid tumors: Implications for drug delivery. Cancer Res. 55:5451-5458; 1995.
23. Caulser, C.; Macapinlac, H.; Healey, J.; Ghavimi, F.; Meyers, P.; Wollner, N.; Kalaigian, J.; Kostakoglu, L.; Abdel-Dayem, H. M.; Yen, S. D. J.; Larson, S. M. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors. Clin. Nucl. Med. 17:565-572; 1992.
24. Sehweil, A.; El-Sayed, M.; Ziada, G.; Al-Huda, F.; Mobarak, L.; Omar, Y. T.; Abdel-Dayem, H. M.; McKillop, J. H. Thallium-201 kinetics in malignant tumors. J. Nucl. Med. 27:1033; 1986.
25. 99mTc-human serum albumin for assessment of the effect of hypertensive treatment with angiotensin II infusion on tumour circulation. Nucl. Med. Commun. 17:160-163; 1996.
26. 201Tl scintigraphy. J. Juzen Med. Soc. 103:453-4164; 1994.
27. Kotanagi, H.; Takahashi, T.; Masuko, T.; Hashimoto, Y.; Koyama, K. A monoclonal antibody against human colon cancers. Tohoku J. Exp. Med. 148:353-360; 1986.
28. Paik, C. H.; Ebbert, M. A.; Murphy, P. R.; Lassman, C. R.; Reba, R. C.; Eckelman, W. C.; Pak, K. Y.; Powe, J.; Steplewski, Z.; Koprowski, H. Factors influencing DTPA conjugation with anti-bodies by cyclic DTPA anhydride. J. Nucl. Med. 24:1158-1163; 1983.
29. DeNardo, S. J.; Kramer, E. L.; O'Donnell, R. T.; Richman, C. M.; Salako, Q. A.; Shen, S.; Noz, M.; Glenn, S. D.; Ceriani, R. L.; DeNardo, G. L. Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: Results of a phase I clinical trial. J. Nucl. Med. 38:1180-1185; 1997.
30. Dillman, L. T.; Von der Lage, F. C. Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation. MIRD Pamphlet No. 10. New York: The Society of Nuclear Medicine; 1975:59.
31. Kinuya, S.; Yokoyama, K.; Tega, H.; Hiramatsu, T.; Konishi, S.; Yamamoto, W.; Shuke, N.; Aburano, T.; Watanabe, N.; Takayama, T.; Michigishi, T.; Tonami, N. Rhenium-186-mercaptoace-thyltriglycine-labeled monoclonal antibody for radioimmunotherpay: In vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice. Jpn. J. Cancer Res. 89:870-878; 1998.
32. Li, C. J.; Miyamoto, Y.; Maeda, H. Augumentation of tumor delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure. Br. J. Cancer 67:975-980; 1993.